The impact of microscopic extrathyroid extension on outcome in patients with clinical T1 and T2 well-differentiated thyroid cancer.
暂无分享,去创建一个
J. Shah | I. Ganly | Snehal G. Patel | R. Tuttle | A. Shaha | I. Nixon | F. Palmer | Monica M. Whitcher | S. Patel
[1] J. Ricarte-Filho,et al. Molecular, morphologic, and outcome analysis of thyroid carcinomas according to degree of extrathyroid extension. , 2010, Thyroid : official journal of the American Thyroid Association.
[2] I. Sugitani,et al. Re-Evaluation of Histopathological Factors Affecting Prognosis of Differentiated Thyroid Carcinoma in an Iodine-Sufficient Country , 2010, World Journal of Surgery.
[3] Stephanie L. Lee,et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. , 2009, Thyroid : official journal of the American Thyroid Association.
[4] N. Bhattacharyya,et al. Survival impact of treatment options for papillary microcarcinoma of the thyroid , 2009, The Laryngoscope.
[5] J. Shah,et al. Risk group stratification and prognostic factors in papillary carcinoma of thyroid , 1996, Annals of Surgical Oncology.
[6] A. Miyauchi,et al. Prognostic Significance of Extrathyroid Extension of Papillary Thyroid Carcinoma: Massive but Not Minimal Extension Affects the Relapse-free Survival , 2006, World Journal of Surgery.
[7] A. Miyauchi,et al. Minimal Extrathyroid Extension Does Not Affect the Relapse-Free Survival of Patients with Papillary Thyroid Carcinoma Measuring 4 cm or Less over the Age of 45 Years , 2005, Surgery Today.
[8] C. Esselstyn,et al. Conservative management of patients with intrathyroidal well-differentiated follicular thyroid carcinoma. , 2001, Surgery.
[9] P. Ladenson,et al. Prospective multicenter study of thyroid carcinoma treatment , 1998 .
[10] P. Ladenson,et al. Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. , 1998, Cancer.
[11] J. Shah,et al. Patterns of failure in differentiated carcinoma of the thyroid based on risk groups , 1998, Head & neck.
[12] J. Shah,et al. Differentiated carcinoma of the thyroid with extrathyroidal extension. , 1995, American journal of surgery.
[13] S. Jhiang,et al. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. , 1994, The American journal of medicine.
[14] E. Bergstralh,et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. , 1993, Surgery.
[15] M. Kaplan,et al. Ablative radioactive iodine therapy for apparently localized thyroid carcinoma. A decision analytic perspective. , 1990, Endocrinology and metabolism clinics of North America.
[16] B. Cady,et al. An expanded view of risk-group definition in differentiated thyroid carcinoma. , 1988, Surgery.
[17] L. Woolner,et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestations, pathologic findings, therapy, and outcome. , 1986, Mayo Clinic proceedings.